Katrina L. Creech

2.4k citations

23 papers · 1.4k indexed · h-index 16

Co-authors: Derek J. Parks Timothy M. Willson Stacey A. Jones Linda B. Moore Curt D. Haffner Joan G. Wilson Adam M. Fivush Gyan Chandra
Topics: Drug Transport and Resistance Mechanisms (6 papers)Hepatitis C virus research (5 papers)Estrogen and related hormone effects (4 papers)
Cited by: Oncology Pharmacology Hepatology
Journals: Cancer Research Scientific Reports Journal of Medicinal Chemistry
Partner nations: United States United Kingdom Australia

In The Last Decade

Katrina L. Creech

23 papers receiving 1.4k citations

Peers

Countries citing papers authored by Katrina L. Creech

Since Specialization

Citations

This map shows the geographic impact of Katrina L. Creech's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katrina L. Creech with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katrina L. Creech more than expected).

Fields of papers citing papers by Katrina L. Creech

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katrina L. Creech. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katrina L. Creech. The network helps show where Katrina L. Creech may publish in the future.

Co-authorship network of co-authors of Katrina L. Creech

This figure shows the co-authorship network connecting the top 25 collaborators of Katrina L. Creech. A scholar is included among the top collaborators of Katrina L. Creech based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katrina L. Creech. Katrina L. Creech is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	595 Differential ligand binding distinguishes therapeutic from pathologic Aryl Hydrocarbon Receptor (AhR) modulating agents: Implications for inflammatory skin disease 2020 ·Journal of Investigative Dermatology ·Steven G. Smith,(unknown),Katrina L. Creech,David J. Rickard,Channa Jayawickreme,(unknown),Fraydoon Rastinejad,David S. Rubenstein	9
2	Design of N -Benzoxaborole Benzofuran GSK8175—Optimization of Human Pharmacokinetics Inspired by Metabolites of a Failed Clinical HCV Inhibitor 2019 ·Journal of Medicinal Chemistry ·Pek Y. Chong,J. Brad Shotwell,John F. Miller,Daniel J. Price,(unknown),Christian Voitenleitner,Amanda Mathis,Shawn P. Williams,Jeffrey J. Pouliot,Katrina L. Creech,Feng Wang,Jing Fang,(unknown),Vincent W.‐F. Tai,Elizabeth M. Turner,Kirsten M. Kahler,Renae M. Crosby,Andrew J. Peat	45
3	Gram-scale synthesis of FICZ, a photoreactive endogenous ligand of the aryl hydrocarbon receptor 2019 ·Scientific Reports ·Cunyu Zhang,Katrina L. Creech,William J. Zuercher,Timothy M. Willson	11
4	Novel heterocyclic scaffolds of GW4064 as farnesoid X receptor agonists 2014 ·Bioorganic & Medicinal Chemistry Letters ·Terrence L. Smalley,Sharon Boggs,Justin A. Caravella,Lihong Chen,Katrina L. Creech,David N. Deaton,István Káldor,Derek J. Parks	15
5	Design and synthesis of spirocyclic compounds as HCV replication inhibitors by targeting viral NS4B protein 2014 ·Bioorganic & Medicinal Chemistry Letters ·Vincent W.‐F. Tai,Dulce Garrido,Daniel J. Price,Andrew Maynard,Jeffrey J. Pouliot,Zhiping Xiong,(unknown),Katrina L. Creech,(unknown),Todd M. Baughman,Andrew J. Peat	21
6	In Vitro Characterization of GSK2485852, a Novel Hepatitis C Virus Polymerase Inhibitor 2013 ·Antimicrobial Agents and Chemotherapy ·Christian Voitenleitner,Renae M. Crosby,(unknown),Katja Remlinger,Jessica Vamathevan,Amy Wang,Shihyun You,John Johnson,(unknown),Stephanie Van Horn,Joseph Horton,Katrina L. Creech,J. Brad Shotwell,Zhi Hong,Robert Hamatake	10
7	Discovery of Selective Small Molecule Type III Phosphatidylinositol 4-Kinase Alpha (PI4KIIIα) Inhibitors as Anti Hepatitis C (HCV) Agents 2013 ·Journal of Medicinal Chemistry ·(unknown),(unknown),J. Brad Shotwell,Scott H. Dickerson,(unknown),Octerloney B. McDonald,(unknown),Katrina L. Creech,Susan L. Strum,Amanda Mathis,(unknown),(unknown),J. Botyánszki	56
8	Conformationally constrained farnesoid X receptor (FXR) agonists: Alternative replacements of the stilbene 2011 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Justin A. Caravella,Lihong Chen,Katrina L. Creech,David N. Deaton,Kevin P. Madauss,Harry B. Marr,Aaron B. Miller,Frank Navas,Derek J. Parks,Paul K. Spearing,Dan Todd,Shawn P. Williams,G. Bruce Wisely	28
9	764 IN VITRO PROFILING OF GSK2336805, A POTENT AND SELECTIVE INHIBITOR OF HCV NS5A 2011 ·Journal of Hepatology ·Jill Bechtel,Renae M. Crosby,(unknown),(unknown),Stephanie Van Horn,Joseph Horton,Katrina L. Creech,(unknown),Christian Voitenleitner,Jessica Vamathevan,(unknown),Andreas Spaltenstein,Wieslaw M. Kazmierski,Christopher D. Roberts,Robert Hamatake	7
10	Conformationally constrained farnesoid X receptor (FXR) agonists: Heteroaryl replacements of the naphthalene 2010 ·Bioorganic & Medicinal Chemistry Letters ·Jonathan Y. Bass,Justin A. Caravella,Lihong Chen,Katrina L. Creech,David N. Deaton,Kevin P. Madauss,Harry B. Marr,Robert B. McFadyen,Aaron B. Miller,Wendy Y. Mills,Frank Navas,Derek J. Parks,Terrence L. Smalley,Paul K. Spearing,Dan Todd,Shawn P. Williams,G. Bruce Wisely	53
11	Substituted isoxazole analogs of farnesoid X receptor (FXR) agonist GW4064 2009 ·Bioorganic & Medicinal Chemistry Letters ·Jonathan Y. Bass,Richard D. Caldwell,Justin A. Caravella,Lihong Chen,Katrina L. Creech,David N. Deaton,Kevin P. Madauss,Harry B. Marr,Robert B. McFadyen,Aaron B. Miller,Derek J. Parks,Dan Todd,Shawn P. Williams,G. Bruce Wisely	45
12	FXR agonist activity of conformationally constrained analogs of GW 4064 2009 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Jonathan Y. Bass,Richard D. Caldwell,Justin A. Caravella,Lihong Chen,Katrina L. Creech,David N. Deaton,Kevin P. Madauss,Harry B. Marr,Robert B. McFadyen,Aaron B. Miller,Frank Navas,Derek J. Parks,Paul K. Spearing,Dan Todd,Shawn P. Williams,G. Bruce Wisely	56
13	Conformationally constrained farnesoid X receptor (FXR) agonists: Naphthoic acid-based analogs of GW 4064 2008 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Jonathan Y. Bass,Richard D. Caldwell,Justin A. Caravella,Lihong Chen,Katrina L. Creech,David N. Deaton,Stacey A. Jones,István Káldor,Yaping Liu,Kevin P. Madauss,Harry B. Marr,Robert B. McFadyen,Aaron B. Miller,Frank Navas,Derek J. Parks,Paul K. Spearing,Dan Todd,Shawn P. Williams,G. Bruce Wisely	118
14	Synthesis of novel substituted 2-phenylpyrazolopyridines with potent activity against herpesviruses 2005 ·Bioorganic & Medicinal Chemistry ·Kristjan S. Gudmundsson,Brian A. Johns,Zhicheng Wang,Elizabeth M. Turner,Scott H. Allen,George A. Freeman,F. Leslie Boyd,Connie J. Sexton,Dean W. Selleseth,(unknown),Katrina L. Creech	48
15	Synthesis of C-6 substituted pyrazolo[1,5-a]pyridines with potent activity against herpesviruses 2005 ·Bioorganic & Medicinal Chemistry ·Scott H. Allen,Brian A. Johns,Kristjan S. Gudmundsson,George A. Freeman,F. Leslie Boyd,(unknown),Dean W. Selleseth,Katrina L. Creech,(unknown)	38
16	Pyrazolopyridine antiherpetics: SAR of C2′ and C7 amine substituents 2005 ·Bioorganic & Medicinal Chemistry ·Brian A. Johns,Kristjan S. Gudmundsson,Elizabeth M. Turner,Scott H. Allen,Vicente Sámano,John A. Ray,George A. Freeman,F. Leslie Boyd,Connie J. Sexton,Dean W. Selleseth,Katrina L. Creech,(unknown)	50
17	Guggulsterone Activates Multiple Nuclear Receptors and Induces CYP3A Gene Expression through the Pregnane X Receptor 2004 ·Journal of Pharmacology and Experimental Therapeutics ·(unknown),Xunshan Ding,Katrina L. Creech,Bryan Goodwin,Brian M. Kelley,Jeff L. Staudinger	87
18	Novel Benzophenones as Non-nucleoside Reverse Transcriptase Inhibitors of HIV-1 2004 ·Journal of Medicinal Chemistry ·Joseph H. Chan,George A. Freeman,Jeffrey H. Tidwell,Karen R. Romines,Lee T. Schaller,Jill R. Cowan,(unknown),(unknown),C. Webster Andrews,David J. Reynolds,Marty St. Clair,Richard Hazen,(unknown),Katrina L. Creech,(unknown),Steven A. Short,Kurt Weaver,George W. Koszalka,Lawrence R. Boone	52
19	GABAA Receptor α1 and β2 Subunit Null Mutant Mice: Behavioral Responses to Ethanol 2003 ·Journal of Pharmacology and Experimental Therapeutics ·Yuri A. Blednov,Danielle Walker,H. Alva,Katrina L. Creech,(unknown),R. Adron Harris	84
20	Identification of a Chemical Tool for the Orphan Nuclear Receptor FXR 2000 ·Journal of Medicinal Chemistry ·Patrick Maloney,Derek J. Parks,Curt D. Haffner,Adam M. Fivush,Gyan Chandra,Kelli D. Plunket,Katrina L. Creech,Linda B. Moore,Joan G. Wilson,Michael C. Lewis,Stacey A. Jones,Timothy M. Willson	464

About Katrina L. Creech

Katrina L. Creech is a scholar working on Hepatology, Physiology and Virology, having authored 23 papers that have together received 1.4k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (6 papers), Hepatitis C virus research (5 papers) and Estrogen and related hormone effects (4 papers). The work is most often cited by research in Oncology (651 citations), Pharmacology (188 citations) and Hepatology (116 citations). Katrina L. Creech has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Derek J. Parks, Timothy M. Willson, Stacey A. Jones, Linda B. Moore, Curt D. Haffner, Joan G. Wilson, Adam M. Fivush, Gyan Chandra, Patrick Maloney and Michael C. Lewis. Their work appears in journals such as Cancer Research, Scientific Reports and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact